Thirumalai Chemicals Toekomstige groei
Future criteriumcontroles 0/6
Momenteel beschikken we niet over voldoende analisten om de groei en omzet voor Thirumalai Chemicals te voorspellen.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
Chemicals winstgroei | 21.1% |
Inkomstengroei | n/a |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | None |
Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
Geen updates
Recent updates
Thirumalai Chemicals' (NSE:TIRUMALCHM) Dividend Will Be Reduced To ₹1.00
Jul 12Investors Still Aren't Entirely Convinced By Thirumalai Chemicals Limited's (NSE:TIRUMALCHM) Revenues Despite 32% Price Jump
Jul 05Thirumalai Chemicals (NSE:TIRUMALCHM) Will Pay A Smaller Dividend Than Last Year
Jun 28Thirumalai Chemicals Limited (NSE:TIRUMALCHM) Stock Rockets 28% But Many Are Still Ignoring The Company
Apr 13Here's What's Concerning About Thirumalai Chemicals' (NSE:TIRUMALCHM) Returns On Capital
Aug 30Thirumalai Chemicals (NSE:TIRUMALCHM) Is Paying Out Less In Dividends Than Last Year
Jul 07Capital Allocation Trends At Thirumalai Chemicals (NSE:TIRUMALCHM) Aren't Ideal
Mar 07Thirumalai Chemicals (NSE:TIRUMALCHM) Is Paying Out A Larger Dividend Than Last Year
Jul 16Thirumalai Chemicals' (NSE:TIRUMALCHM) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 02Does Thirumalai Chemicals (NSE:TIRUMALCHM) Have A Healthy Balance Sheet?
Jan 31Investors Shouldn't Overlook The Favourable Returns On Capital At Thirumalai Chemicals (NSE:TIRUMALCHM)
Oct 12Estimating The Intrinsic Value Of Thirumalai Chemicals Limited (NSE:TIRUMALCHM)
Jul 27Thirumalai Chemicals (NSE:TIRUMALCHM) Could Easily Take On More Debt
Jul 02Be Wary Of Thirumalai Chemicals (NSE:TIRUMALCHM) And Its Returns On Capital
Mar 23Trade Alert: Sujatha Sampath At Thirumalai Chemicals Limited (NSE:TIRUMALCHM), Has Just Spent ₹997k Buying A Small Number of Shares
Mar 04Can Mixed Fundamentals Have A Negative Impact on Thirumalai Chemicals Limited (NSE:TIRUMALCHM) Current Share Price Momentum?
Mar 02What Type Of Shareholders Make Up Thirumalai Chemicals Limited's (NSE:TIRUMALCHM) Share Registry?
Feb 15Are Insiders Buying Thirumalai Chemicals Limited (NSE:TIRUMALCHM) Stock?
Jan 25Did You Participate In Any Of Thirumalai Chemicals' (NSE:TIRUMALCHM) Incredible 429% Return?
Jan 04Here's Why Thirumalai Chemicals (NSE:TIRUMALCHM) Has A Meaningful Debt Burden
Dec 14What Do The Returns On Capital At Thirumalai Chemicals (NSE:TIRUMALCHM) Tell Us?
Nov 23Is Thirumalai Chemicals Limited's (NSE:TIRUMALCHM) Shareholder Ownership Skewed Towards Insiders?
Oct 23Shareholders Of Thirumalai Chemicals (NSE:TIRUMALCHM) Must Be Happy With Their 256% Total Return
Sep 18In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Thirumalai Chemicals onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.
Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.
Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
9/30/2024 | 20,982 | -335 | -4,955 | 1,588 | N/A |
6/30/2024 | 21,151 | -443 | N/A | N/A | N/A |
3/31/2024 | 20,831 | -388 | -5,737 | 2,371 | N/A |
12/31/2023 | 19,875 | -312 | N/A | N/A | N/A |
9/30/2023 | 20,039 | 1 | -7,831 | -1,121 | N/A |
6/30/2023 | 20,339 | 404 | N/A | N/A | N/A |
3/31/2023 | 21,322 | 898 | -3,086 | 541 | N/A |
12/31/2022 | 22,841 | 1,927 | N/A | N/A | N/A |
9/30/2022 | 23,171 | 2,599 | 2,244 | 3,621 | N/A |
6/30/2022 | 22,221 | 2,762 | N/A | N/A | N/A |
3/31/2022 | 19,982 | 2,812 | 3,287 | 4,023 | N/A |
12/31/2021 | 18,021 | 2,758 | N/A | N/A | N/A |
9/30/2021 | 15,787 | 2,370 | 3,338 | 3,900 | N/A |
6/30/2021 | 13,694 | 2,029 | N/A | N/A | N/A |
3/31/2021 | 10,857 | 1,177 | 1,598 | 2,208 | N/A |
12/31/2020 | 9,804 | 355 | N/A | N/A | N/A |
9/30/2020 | 9,073 | -24 | 1,007 | 1,895 | N/A |
6/30/2020 | 9,082 | -90 | N/A | N/A | N/A |
3/31/2020 | 10,848 | 232 | 369 | 1,397 | N/A |
12/31/2019 | 11,191 | 385 | N/A | N/A | N/A |
9/30/2019 | 11,979 | 512 | -767 | 556 | N/A |
6/30/2019 | 12,927 | 944 | N/A | N/A | N/A |
3/31/2019 | 12,610 | 1,136 | 407 | 2,339 | N/A |
12/31/2018 | 12,786 | 1,355 | N/A | N/A | N/A |
9/30/2018 | 12,997 | 1,753 | N/A | N/A | N/A |
6/30/2018 | 12,478 | 1,685 | N/A | N/A | N/A |
3/31/2018 | 13,120 | 1,704 | N/A | 808 | N/A |
12/31/2017 | 12,921 | 1,497 | N/A | N/A | N/A |
9/30/2017 | 11,947 | 1,134 | N/A | N/A | N/A |
6/30/2017 | 11,450 | 835 | N/A | N/A | N/A |
3/31/2017 | 10,285 | 707 | N/A | 1,081 | N/A |
12/31/2016 | 9,652 | 758 | N/A | N/A | N/A |
9/30/2016 | 9,214 | 646 | N/A | N/A | N/A |
6/30/2016 | 8,972 | 333 | N/A | N/A | N/A |
3/31/2016 | 9,442 | 322 | N/A | 1,257 | N/A |
12/31/2015 | 9,254 | 59 | N/A | N/A | N/A |
9/30/2015 | 9,796 | -130 | N/A | N/A | N/A |
6/30/2015 | 10,313 | 61 | N/A | N/A | N/A |
3/31/2015 | 10,723 | -137 | N/A | 1,536 | N/A |
12/31/2014 | 11,462 | -186 | N/A | N/A | N/A |
9/30/2014 | 11,755 | 15 | N/A | N/A | N/A |
6/30/2014 | 12,716 | 131 | N/A | N/A | N/A |
3/31/2014 | 12,762 | 119 | N/A | 1,331 | N/A |
12/31/2013 | 13,255 | 220 | N/A | N/A | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van TIRUMALCHM boven de spaarquote ( 6.7% ) ligt.
Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van TIRUMALCHM naar verwachting sneller zal groeien dan de markt Indian
Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van TIRUMALCHM naar verwachting de komende 3 jaar aanzienlijk zal groeien.
Omzet versus markt: Er zijn onvoldoende gegevens om te bepalen of de omzet van TIRUMALCHM naar verwachting sneller zal groeien dan de markt Indian.
Hoge groei-inkomsten: Er zijn onvoldoende gegevens om te bepalen of de omzet van TIRUMALCHM naar verwachting sneller zal groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van TIRUMALCHM naar verwachting over 3 jaar hoog zal zijn